The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
A new study from our scientists has found that treating melanoma cells with an HIV drug could make them more sensitive to a 'targeted' cancer drug.
An HIV drug could stop one of the early changes in skin cancer cells that leads to them becoming resistant to treatment.
A blood test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing.
Monday morning’s papers had lots of coverage of research presented at yesterday’s conference: data on the unacceptably high death rates of patients diagnosed as an...
In recent years, a multi-billion pound global industry has sprung up selling antioxidant supplements.
Various pills and potions are heavily promoted as being ‘good...
After decades in the shadows, treatments that encourage a patient’s own immune system to target their cancer – known as immunotherapy – have emerged as one of the...
A new immunotherapy drug has been approved for NHS patients in England whose melanoma has stopped responding to previous treatments.